Patents Represented by Attorney, Agent or Law Firm David Vance
  • Disubstituted pyrazolines and triazolines as factor Xa inhibitors
    Patent number: 6191159
    Abstract: The present application describes disubstituted pyrazolines and triazolines of formulae I and II: or pharmaceutically acceptable salt forms thereof, wherein one of M1 and M2 maybe N and D may be a variety of N-containing groups, which are useful as inhibitors of factor Xa.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: February 20, 2001
    Assignee: Dupont Pharmaceuticals Company
    Inventor: Donald J. P. Pinto
  • Phenyl-isoxazoles as factor XA Inhibitors
    Patent number: 6187797
    Abstract: The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or S and D may be C(═NH)NH2, which are useful as inhibitors of factor Xa.
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: February 13, 2001
    Assignee: Dupont Pharmaceuticals Company
    Inventors: James Russell Pruitt, John Matthew Fevig, Mimi Lifen Quan, Donald Joseph Phillip Pinto